"Modern Family" beauty Sarah Hyland is usually known for bringing the laughs. But now, the 21-year-old actress is making a very serious revelation – she underwent a kidney transplant in April. In a new interview with Seventeen magazine, Sarah…
Caroline Rochon, MD, joins Hartford Hospital – Norwalk Plus Magazine
Caroline Rochon, MD, joins Hartford HospitalNorwalk Plus MagazineHer areas of interest include liver transplantation, kidney transplantation, kidney living donor surgery, hepatobiliary surgery and vascular access surgery. Dr. Rochon was previously in c…
Caroline Rochon, MD, joins Hartford Hospital – Stamford Plus Magazine
Caroline Rochon, MD, joins Hartford HospitalStamford Plus MagazineHer areas of interest include liver transplantation, kidney transplantation, kidney living donor surgery, hepatobiliary surgery and vascular access surgery. Dr. Rochon was previously in …
Washington University receives $8 million to lead international childhood malnutrition effort
( Washington University School of Medicine ) Jeffrey I. Gordon, M.D., at Washington University School of Medicine in St. Louis, will lead an international team of scientists to find new ways to diagnose, treat and prevent a critical global health probl…
Modern Family Star Sarah Hyland Reveals She Had Kidney Transplant
Modern Family star Sarah Hyland quickly learned the importance of, well, family—and then some—after recently undergoing a kidney transplant. The 21-year-old actress reveals…
Sarah Hyland of ‘Modern Family’ underwent kidney transplant in April
Sarah Hyland has revealed that she underwent a kidney transplant in April. The “Modern Family” actress made the announcement in the current issue of Seventeen magazine and on Monday’s “ Good Morning America .” Read full article >>
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's … – Sacramento Bee
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's …Sacramento BeeMeanwhile, Biogen and partner Abbott (NYSE:ABT) moved their MS candidate, daclizumab, into a two-year phase III study (DECIDE) in July 2010. Daclizumab is bein…
Organ donor event raises more than $5000 – Alton Telegraph
Organ donor event raises more than $5000Alton TelegraphBy DAN BRANNAN The Spring Organ/Donor/Tissue Donation Awareness 5K Run/2-Mile Walk once again created awareness and funds for donor registration and the Jersey Community Hospital Emergency Room exp…
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's … – PR Newswire (press release)
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's …PR Newswire (press release)Meanwhile, Biogen and partner Abbott (NYSE: ABT) moved their MS candidate, daclizumab, into a two-year phase III study (DECIDE) in July 2010. Dacl…
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's … – NASDAQ
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's …NASDAQMeanwhile, Biogen and partner Abbott ( ABT ) moved their MS candidate, daclizumab, into a two-year phase III study (DECIDE) in July 2010. Daclizumab is being evaluated…